Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer
Authors
Keywords
CD44 targeting, HA-PEI/HA-PEG nanoparticle, multidrug resistance, ovarian cancer, siRNA delivery
Journal
PHARMACEUTICAL RESEARCH
Volume 32, Issue 6, Pages 2097-2109
Publisher
Springer Nature
Online
2014-12-17
DOI
10.1007/s11095-014-1602-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of Drug Resistance in Ovarian Adenocarcinoma Using Chemotherapy Entrapped in Hyaluronan-Grafted Nanoparticle Clusters
- (2014) Keren Cohen et al. ACS Nano
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Role of integrated cancer nanomedicine in overcoming drug resistance
- (2013) Arun K. Iyer et al. ADVANCED DRUG DELIVERY REVIEWS
- A review of the current status of siRNA nanomedicines in the treatment of cancer
- (2013) Pauline Resnier et al. BIOMATERIALS
- Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
- (2013) Shanthi Ganesh et al. BIOMATERIALS
- Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
- (2013) V. Shah et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
- (2013) Shanthi Ganesh et al. JOURNAL OF CONTROLLED RELEASE
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
- (2013) João Conde et al. Frontiers in Pharmacology
- Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
- (2013) Shanthi Ganesh et al. Molecular Therapy-Nucleic Acids
- A review of nanocarriers for the delivery of small interfering RNA
- (2012) Prashant Kesharwani et al. BIOMATERIALS
- Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
- (2012) Z. Duan et al. CLINICAL CANCER RESEARCH
- The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors
- (2012) D. Vergara et al. CURRENT CANCER DRUG TARGETS
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Combinatorial-Designed Multifunctional Polymeric Nanosystems for Tumor-Targeted Therapeutic Delivery
- (2011) Sampath C. Abeylath et al. ACCOUNTS OF CHEMICAL RESEARCH
- Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy
- (2011) Ki Young Choi et al. ACS Nano
- Controlled Intracellular Release of Doxorubicin in Multidrug-Resistant Cancer Cells by Tuning the Shell-Pore Sizes of Mesoporous Silica Nanoparticles
- (2011) Yu Gao et al. ACS Nano
- A novel tumor-targeted delivery system with hydrophobized hyaluronic acid–spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery
- (2011) Yan Shen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Treatment-Related Protein Biomarker Expression Differs between Primary and Recurrent Ovarian Carcinomas
- (2011) D. A. Zajchowski et al. MOLECULAR CANCER THERAPEUTICS
- Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles
- (2010) Jiaqi Wang et al. BIOMATERIALS
- PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo
- (2010) Ki Young Choi et al. BIOMATERIALS
- Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells
- (2010) Yaprak Dönmez et al. BIOMEDICINE & PHARMACOTHERAPY
- Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
- (2009) H Chen et al. BRITISH JOURNAL OF CANCER
- Target Specific Intracellular Delivery of siRNA/PEI−HA Complex by Receptor Mediated Endocytosis
- (2009) Ge Jiang et al. MOLECULAR PHARMACEUTICS
- NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance
- (2009) Zhenfeng Duan et al. PLoS One
- Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
- (2008) Marie Morille et al. BIOMATERIALS
- Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular delivery of siRNA
- (2008) Ge Jiang et al. BIOPOLYMERS
- Combinatorial design of biomaterials for drug delivery: opportunities and challenges
- (2008) Latrisha K Petersen et al. Expert Opinion on Drug Delivery
- Preparation and characterization of HA–PEG–PCL intelligent core–corona nanoparticles for delivery of doxorubicin
- (2008) Awesh Kumar Yadav et al. JOURNAL OF DRUG TARGETING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started